Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion type Assertion NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_head.
- NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion wasGeneratedBy ECO_0000203 NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_provenance.
- NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion wasDerivedFrom befree-20150227 NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_provenance.
- NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion SIO_000772 22997141 NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_provenance.
- NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion evidence source_evidence_literature NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_provenance.
- NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_provenance.